Literature DB >> 21931473

Pharmacogenomics in clinical practice: reality and expectations.

C Lee Ventola.   

Abstract

Year:  2011        PMID： 21931473      PMCID： PMC3171815     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  13 in total

Review 1.  Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.

Authors:  Alessio Squassina; Mirko Manchia; Vangelis G Manolopoulos; Mehmet Artac; Christina Lappa-Manakou; Sophia Karkabouna; Konstantinos Mitropoulos; Maria Del Zompo; George P Patrinos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

Review 2.  Direct-to-consumer genome testing: opportunities for pharmacogenomics research?

Authors:  Barbara Prainsack; Howard Wolinsky
Journal:  Pharmacogenomics       Date:  2010-05       Impact factor: 2.533

Review 3.  Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice.

Authors:  Felix W Frueh
Journal:  Pharmacogenomics       Date:  2010-05       Impact factor: 2.533

4.  Personalized medicine: part 1: evolution and development into theranostics.

Authors:  F Randy Vogenberg; Carol Isaacson Barash; Michael Pursel
Journal:  P T       Date:  2010-10

5.  Personalized medicine: part 2: ethical, legal, and regulatory issues.

Authors:  F Randy Vogenberg; Carol Isaacson Barash; Michael Pursel
Journal:  P T       Date:  2010-11

Review 6.  Nutrigenomics and ethics interface: direct-to-consumer services and commercial aspects.

Authors:  Nola M Ries; David Castle
Journal:  OMICS       Date:  2008-12

Review 7.  Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.

Authors:  Eric E Walk
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

Review 8.  Ethical and social issues in pharmacogenomics testing.

Authors:  S J H Vijverberg; T Pieters; M C Cornel
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 9.  Clinical cancer genomics: how soon is now?

Authors:  Barry S Taylor; Marc Ladanyi
Journal:  J Pathol       Date:  2010-10-28       Impact factor: 7.996

Review 10.  Pathology practice and pharmacogenomics.

Authors:  Ronald Ja Trent
Journal:  Pharmacogenomics       Date:  2010-01       Impact factor: 2.533
View more
  12 in total

1.  Documenting Pharmacogenomic Testing with CPT Codes.

Authors:  Erik Hefti; Javier G Blanco
Journal:  J AHIMA       Date:  2016-01

Review 2.  CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?

Authors:  Aniwaa Owusu Obeng; Eric F Egelund; Abdullah Alsultan; Charles A Peloquin; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2014-02-07       Impact factor: 4.705

3.  Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.

Authors:  Rebecca Wellmann; Brittany A Borden; Keith Danahey; Rita Nanda; Blase N Polite; Walter M Stadler; Mark J Ratain; Peter H O'Donnell
Journal:  Cancer       Date:  2018-05-09       Impact factor: 6.860

Review 4.  Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicine.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Alessandra Dalla Gassa; Antonio Lupo
Journal:  Int J Mol Sci       Date:  2015-02-17       Impact factor: 5.923

5.  Proposal for a Pharmacogenetic Decision Algorithm.

Authors:  Saeed K Alzghari; Lori Blakeney; Kerry Anne Rambaran
Journal:  Cureus       Date:  2017-05-30

6.  Gold nanoparticles - an optical biosensor for RNA quantification for cancer and neurologic disorders diagnosis.

Authors:  Sherif M Shawky; Ahmed M Awad; Arwa A Abugable; Sherif F El-Khamisy
Journal:  Int J Nanomedicine       Date:  2018-11-29

Review 7.  Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases.

Authors:  Young Hee Choi; Chang Yeob Han; Kwi Suk Kim; Sang Geon Kim
Journal:  Toxicol Res       Date:  2019-10-15

Review 8.  Bringing microbiome-drug interaction research into the clinic.

Authors:  Leah Guthrie; Libusha Kelly
Journal:  EBioMedicine       Date:  2019-05-28       Impact factor: 8.143

9.  Engineering Requirements of a Herpes Simplex Virus Patient Registry: Discovery Phase of a Real-World Evidence Platform to Advance Pharmacogenomics and Personalized Medicine.

Authors:  Svitlana Surodina; Ching Lam; Caroline de Cock; Michelle van Velthoven; Madison Milne-Ives; Edward Meinert
Journal:  Biomedicines       Date:  2019-12-15

10.  Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.

Authors:  Domas Naujokaitis; Virginija Asmoniene; Edmundas Kadusevicius
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.